Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Venous Thrombosis IV: Nursing Management

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advanced micro- & nanostructuring for enhanced biocompatibility of stainless steel by multi-beam and beamshaping technology.

Biomedical materials (Bristol, England)·2023

Same author

Urinary incontinence: vaginal delivery versus instrumental delivery.

Ceska gynekologie·2021

Same author

Th e role of CDK12 in tumor bio logy.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2020

Same author

The effect of physiotherapy intervention on the load of the foot and low back pain in pregnancy.

Ceska gynekologie·2020

Same author

Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2019

Same author

Echogenic foci in fetal heart from a pediatric cardiologists point of view.

Ceska gynekologie·2019

Search research articles

Related Experiment Videos

[Antithrombotic therapy in pregnancy].

M Procházka¹, J Procházková, L Slavík

¹Porodnicko-gynekologická klinika Lékarské fakulty UP a FN Olomouc. martinprochazka@hotmail.com

Vnitrni Lekarstvi

|March 25, 2010

Summary

Deep venous thrombosis (DVT) is a serious pregnancy complication. Management involves heparin treatment and risk stratification based on VTE history and thrombophilia.

Area of Science:

Obstetrics and Gynecology
Hematology
Vascular Medicine

Context:

Deep venous thrombosis (DVT) is a significant complication during pregnancy and the postpartum period, despite low maternal mortality rates.
The pathogenesis of DVT in pregnancy is multifactorial, involving Virchow's triad: vascular stasis, hypercoagulability, and vascular trauma.

Purpose:

To outline the primary treatment options for DVT in pregnancy, focusing on low molecular weight heparins (LMWH) and unfractionated heparins (UFH).
To emphasize the treatment goals: preventing thrombus extension, post-thrombotic syndrome, and pulmonary embolism.

Summary:

Heparins are the recommended treatment for DVT during pregnancy and puerperium.
Risk stratification for venous thromboembolism (VTE) in pregnant women involves assessing prior VTE events (provoked vs. unprovoked) and inherited thrombophilia.

Related Experiment Videos

Impact:

Informs clinical management strategies for pregnant women at risk of VTE.
Aims to improve patient outcomes by preventing serious complications like pulmonary embolism.